2019
DOI: 10.1016/j.molmet.2019.06.006
|View full text |Cite
|
Sign up to set email alerts
|

Metabolically phenotyped pancreatectomized patients as living donors for the study of islets in health and diabetes

Abstract: BackgroundThe availability of human pancreatic islets with characteristics closely resembling those present in vivo is instrumental for ex vivo studies in diabetes research.Scope of reviewIn this review we propose metabolically phenotyped surgical patients as a novel source of pancreatic tissue for islet research. Laser Capture Microdissection from snap frozen surgical specimens is a relatively simple, reproducible and scalable method to isolate islets of highest purity for many types of “omics” analyses. Fres… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2

Relationship

3
5

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 26 publications
0
9
0
1
Order By: Relevance
“…Notwithstanding the potential impacts of the pancreatic tumours being resected on metabolic phenotypes, this approach has allowed the direct linking of islet transcript profiles and expression quantitative trait loci (eQTL) with impaired glucose tolerance and type 2 diabetes in patients [39] and may address some of the quality concerns inherent to the study of islets isolated from pancreases of organ donors, such as the potential impact of prolonged ischaemic times or hospital stays [38]. This approach is now suggested as a source of living donor tissue and live-islet assessment [40] which would allow direct correlations spanning from cell physiology, to molecular genetic and genomic profiling, to in vivo human phenotypes. Although many patient samples (>100) have been assessed for molecular profiling using lasercaptured islets from fixed pancreas samples, it remains to be determined how efficiently this can be adapted to the in vitro assessment of live islets.…”
Section: Increasing Scale: Connecting Molecular and Functional Phenotmentioning
confidence: 99%
“…Notwithstanding the potential impacts of the pancreatic tumours being resected on metabolic phenotypes, this approach has allowed the direct linking of islet transcript profiles and expression quantitative trait loci (eQTL) with impaired glucose tolerance and type 2 diabetes in patients [39] and may address some of the quality concerns inherent to the study of islets isolated from pancreases of organ donors, such as the potential impact of prolonged ischaemic times or hospital stays [38]. This approach is now suggested as a source of living donor tissue and live-islet assessment [40] which would allow direct correlations spanning from cell physiology, to molecular genetic and genomic profiling, to in vivo human phenotypes. Although many patient samples (>100) have been assessed for molecular profiling using lasercaptured islets from fixed pancreas samples, it remains to be determined how efficiently this can be adapted to the in vitro assessment of live islets.…”
Section: Increasing Scale: Connecting Molecular and Functional Phenotmentioning
confidence: 99%
“…The islets of Langerhans, which are clusters of specialized endocrine cells that are essential to maintain glucose homeostasis, play a central role in the etiology of T2D ( Eizirik et al, 2020 ; Krentz and Gloyn, 2020 ). Because human islets are difficult to obtain ( Barovic et al, 2019 ; Burgarella et al, 2013 ; Meier et al, 2015 ), large multi-tissue resources such as GTEx do not contain islet data and at best use whole pancreas as a proxy, despite the fact that 97% of the pancreatic tissue consists of exocrine cells that mask islet signals. Hence, the development of publicly available resources and tools that include data on islets is essential to translate T2D genetic signals into molecular and physiological mechanisms.…”
Section: Introductionmentioning
confidence: 99%
“…Um Einblicke in die Mechanismen zu gewinnen, die für das Fortschreiten der Betazelldysfunktion bei Typ-2-Diabetes (T2D) verantwortlich sind, baut das DZD die "Human Islet Biobank" auf. Darin werden pankreatisches Gewebe und Blutproben von metabolisch charakterisierten Patienten gesammelt, die einer kompletten oder teilweisen Pankreatektomie unterzogen wurden [1]. Die in der Biobank gesammelten Proben werden in verschiedenen Forschungsprojekten verwendet um neue Erkenntnisse insbesondere der Pathogenese von Typ-2-Diabetes zu gewinnen.…”
Section: Biobank Für Pankreatisches Gewebeunclassified